Clevudine, 11th new drug of Korea to approve in May.

Published: 2006-04-04 06:58:00

Updated: 2006-04-04 06:58:00

The KFDA approval of Clevudine, a drug for the treatment of B hepatitis virus, developed by Bukwang seems to be near at hand probably in coming May, which then will be the 11th new drug developed in Korea.

The KFDA took the Central Pharmaceutical Review Council's meeting on March 28 to review ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK